Authors
Latest:
How to prepare a cold chain for looming COVID-19 demandsAgile approaches to averting vaccine wastage will be critical to global delivery ramp-up
Latest:
Include the sales force in incentive compensationBy working with the sales force, incentive plan design can boost a product launch
Latest:
Adopting the TAPA cargo security standards in the pharmaceutical industrySecuring your supply chain
Latest:
Supply chain issues for 2012Tompkins International's annual preview of key pharma supply chain issues
Latest:
Getting from multichannel marketing to customer-centric marketingToday's pharma marketers have the tools to refine their communication efforts to prescribers and patients
Latest:
Rethinking Sample DistributionAs the number of specific services associated with sample distribution has grown, so has the number of service providers a manufacturer might use. It’s time to think about consolidating these services
Latest:
When serializing packages for e-pedigree, go randomThe looming California e-pedigree standards do not specify how to generate product codes, but random codes are easy to produce and essential for supply chain security
Latest:
Artificial Intelligence: Beyond the glamorIt takes gritty work to make an AI application succeed—but it can be worth the effort
Latest:
Gaining Access to the European MarketDistributing products within the European market calls for focused knowledge of national practices
Latest:
The value of real-world data in drug commercializationUsing real-world databases for evidence development has strengths and weaknesses; with electronic health records (EHRs), new approaches are evolving
Latest:
Pharma is under-managing its multi-channel marketing effortsSurvey shows that most digital channels are still experiments with little oversight or follow-through
Latest:
Economic and clinical value: the future of cancer careAn 'expectations convergence' is building in how drug efficacy aligns with patient outcomes
Latest:
A Data-Driven Approach to Contract Performance Monitoring and AnalysisBetter use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively
Latest:
Next-gen AI: Widespread adoption hinges on trustEmbracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement
Latest:
A Process-Based Approach To Aggregate SpendA Process-Based Assessment (PBA) is the first step to analyzing reporting needs
Latest:
Reshaping Biotechnology's Financing Relay RaceThe current economic downturn may fuel the creation of new, more sustainable business models
Latest:
Three Areas to Drive Supply Chain ValueStrategic and proactive thinking are vital in providing supply chain leaders with an opportunity to shift their focus to a more holistic, value-centered approach.
Latest:
Optimizing the Patient Journey Through High-Touch, High-Tech Services for Innovative and Novel TherapiesDana Edwards shares strategies and best practices for developing and implementing high-tech, high-touch patient support programs for innovative and novel therapies to help connect patients to the services they need.
Latest:
Manufacturing at the Speed of AIHow pharma can harness digitalization all the way through commercialization
